Trademark Overview
On Thursday, June 6, 2024, a trademark application was filed for TARRYTMA with the United States Patent and Trademark Office. The USPTO has given the TARRYTMA trademark a serial number of 98589255. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 6, 2024. This trademark is owned by AOP Orphan Pharmaceuticals GmbH. The TARRYTMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and veterinary preparations, namely, cardiovascular treatment preparations acting on the cardiovascular system and CNS; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of tachyarrhythmias, tachycardias and atrial fibrillation; pharmaceutical preparations for the emergency treatment of tachyarrhythmias, tachycardias and atrial fibrillation